Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

NALOXONE HYDROCHLORIDE INTRANASAL SPRAY

Awarded
SPE2D226F2919Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2D226F2919 to DMS Pharmaceutical Group Inc, a Women-Owned Small Business, for the procurement of Naloxone Hydrochloride Intranasal Spray. This specific delivery order, issued under the larger base administrative contract SPE2DX25D9822 which has a total award ceiling of 20,000,000.00 dollars, is for one box of the pharmaceutical product at a unit price of 32.42 dollars. The order is designated as a rated order under the Defense Priorities and Allocation System and falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The delivery is scheduled for July 1, 2026, with the destination being the USNS Sojourner Truth in San Diego, California. The contract is established as FOB Destination, meaning the contractor is responsible for all freight and transportation charges, and the government will perform inspection and acceptance upon arrival. Shipping must be conducted via the fastest traceable means, and parcel post is strictly prohibited. All shipments must include NDC codes and manufacturer CAGE codes for proper identification. The agreement is governed by FAR clauses for commercial items, specifically 52.212-4 and 52.212-5.

General Info

DLA awarded DMS Pharmaceutical Group $32.42 for Naloxone spray delivered by July 2026.

Contract Value

$32.42

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2D2-26-F-2919 - Naloxone Hydrochloride Intranasal Spray

PDF, High priority: read this firstaward
High

SPE2DX-25-D-9822 - Award to DMS Pharmaceutical Group Inc

PDF, High priority: read this firstaward
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2D226F2919 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $32.42 Award Date: 07-01-2026 Delivery order under: SPE2DX25D9822 Line items: - NALOXONE HYDROCHLORIDE INTRANASAL SPRAY (NSN/Part 6505016582463, PR 7017368467)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS